PGAP2
Basic information
Region (hg38): 11:3797724-3826371
Previous symbols: [ "MRT21", "MRT17" ]
Links
Phenotypes
GenCC
Source:
- intellectual disability, autosomal dominant 40 (Definitive), mode of inheritance: AR
- hyperphosphatasia with intellectual disability syndrome 3 (Strong), mode of inheritance: AR
- hyperphosphatasia-intellectual disability syndrome (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hyperphosphatasia with impaired intellectual development syndrome 3 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal; Neurologic | 21629298; 21643797; 23561846; 23561847 |
ClinVar
This is a list of variants' phenotypes submitted to
- Hyperphosphatasia with intellectual disability syndrome 3 (4 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PGAP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 29 | 40 | ||||
nonsense | 2 | |||||
start loss | 2 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 2 | 5 | |||
non coding | 19 | 33 | ||||
Total | 4 | 6 | 36 | 21 | 20 |
Highest pathogenic variant AF is 0.00000657
Variants in PGAP2
This is a list of pathogenic ClinVar variants found in the PGAP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-3797878-G-C | Likely benign (Mar 01, 2023) | |||
11-3797940-A-T | Inborn genetic diseases | Uncertain significance (Mar 29, 2023) | ||
11-3797989-A-G | Hyperphosphatasia with intellectual disability syndrome 3 | Uncertain significance (Aug 08, 2019) | ||
11-3798037-C-T | Benign (May 26, 2021) | |||
11-3798189-T-A | Benign (Jul 27, 2018) | |||
11-3807993-A-C | Benign (Sep 11, 2018) | |||
11-3807994-C-T | Benign (Sep 11, 2018) | |||
11-3808066-CCGG-C | Benign (Sep 11, 2018) | |||
11-3808189-G-C | Benign (Jul 27, 2018) | |||
11-3808296-A-G | Inborn genetic diseases | Conflicting classifications of pathogenicity (Apr 01, 2022) | ||
11-3808299-T-C | Benign (May 01, 2023) | |||
11-3808313-G-A | Likely benign (Jan 01, 2023) | |||
11-3808632-C-G | Benign (Sep 11, 2018) | |||
11-3811027-G-T | Benign (Jul 27, 2018) | |||
11-3811260-A-G | Hyperphosphatasia with intellectual disability syndrome 3 | Likely pathogenic (Apr 01, 2022) | ||
11-3811261-T-G | Hyperphosphatasia with intellectual disability syndrome 3 | Pathogenic (-) | ||
11-3811269-G-A | Inborn genetic diseases | Uncertain significance (Dec 27, 2022) | ||
11-3811289-G-T | Likely benign (Oct 09, 2018) | |||
11-3811305-C-T | Hyperphosphatasia with intellectual disability syndrome 3 | Pathogenic (Apr 04, 2013) | ||
11-3811306-G-A | Inborn genetic diseases | Uncertain significance (Mar 06, 2023) | ||
11-3811311-C-T | Likely benign (Nov 03, 2023) | |||
11-3811312-G-A | Inborn genetic diseases | Uncertain significance (Mar 01, 2024) | ||
11-3811356-G-A | Hypoplasia of the corpus callosum;Micrognathia;Congenital omphalocele • Inborn genetic diseases | Uncertain significance (Oct 20, 2023) | ||
11-3811371-A-G | Autism spectrum disorder | Likely benign (Apr 12, 2022) | ||
11-3811388-C-A | Likely benign (Jun 10, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PGAP2 | protein_coding | protein_coding | ENST00000278243 | 6 | 28648 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.935 | 0.0654 | 125668 | 0 | 80 | 125748 | 0.000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.933 | 168 | 206 | 0.817 | 0.0000138 | 2058 |
Missense in Polyphen | 51 | 66.192 | 0.77049 | 688 | ||
Synonymous | -0.211 | 91 | 88.5 | 1.03 | 0.00000634 | 632 |
Loss of Function | 3.09 | 1 | 13.1 | 0.0765 | 5.59e-7 | 147 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000304 | 0.000304 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000554 | 0.000554 |
European (Non-Finnish) | 0.000519 | 0.000519 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the lipid remodeling steps of GPI-anchor maturation. Required for stable expression of GPI-anchored proteins at the cell surface (By similarity). {ECO:0000250}.;
Intolerance Scores
- loftool
- 0.327
- rvis_EVS
- -0.29
- rvis_percentile_EVS
- 33.2
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.385
- ghis
- 0.535
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.457
Mouse Genome Informatics
- Gene name
- Pgap2
- Phenotype
- skeleton phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- GPI anchor biosynthetic process;protein transport
- Cellular component
- Golgi membrane;endoplasmic reticulum membrane;integral component of membrane
- Molecular function
- protein binding;protein transporter activity